By ABBY GOODNOUGH and KATE ZERNIKE
The manufacturers of the two drugs to treat opioid addiction are competing fiercely for market share and drawing scrutiny from lawmakers and prosecutors.
Published: November 13, 2017 at 07:00PM
from NYT Health http://ift.tt/2yCollI
via IFTTT
from WordPress http://ift.tt/2zYGleb
via IFTTT
No comments:
Post a Comment